Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-29

Antigen presentation and T cell-mediated immunity: membrane trafficking in cross-presentation

Objective

Cross presentation is the process by which professional antigen presenting cells (APCs) present phagocyted antigens in the context of MHC class I molecules (MHC I), to prime CD8+ T cells. Recent findings have revealed that this process takes place in a spe cialized, ER-phagosome mix compartment in the major APCs, like dendritic cells (DCs) and macrophages. This novel compartment was also shown to be self-sufficient for cross presentation. In this context, ER membranes are recruited to the forming phagosome and contribute to peptide translocation and loading on MHC I within phagosomes. Internalised antigens are partially degraded before translocation to the cytosol and processing by the proteasome. Processed peptides are then returned inside phagosome to be loaded on MHC I molecules. Peptide loaded MHC class I molecules then reach the plasma membrane where CD8+ T cells recognize them. Despite the evidences of ER contribution in phagocytosis process, the molecules responsible for ER-phagosome fusion remain unknown as well the origin of the MHC class I molecules involved in cross presentation is still unclear.

Our aim for this proposal is to elucidate the components of the molecular machinery involved in ER-phagosome fusion and to analyse the trafficking of MHC I molecules during cross presentation. SNAREs and Rabs are two protein families involved in membrane trafficking and fusion. We have observed the presence of the ER SNARE Sec22 and the plasma membrane t-SNAREs syntaxin3, syntaxin4 and SNAP23, as well Rab1 and Rab2 on purified phagosomes from D1 dendritic cells. These data suggest that some of them could be involved in ER-phagosome fusion. We will directly address this possibility using both in vivo and in vitro approaches, such as silencing protein production utilizing siRNA, transfection assays, and an in vitro fusion assay between purified ER membranes and purified phagosomes.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2002-MOBILITY-7
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

IIF - Marie Curie actions-Incoming International Fellowships

Coordinator

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
EU contribution
No data
Address
51, avenue du Maréchal de Lattre de Tassigny -Hopital Henri Mondor
CRÉTEIL
France

See on map

Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0